<DOC>
	<DOCNO>NCT00913315</DOCNO>
	<brief_summary>The purpose study determine whether tamsulosin tolterodine effective treatment men low urinary tract symptom chronic prostatitis/chronic pelvic pain syndrome .</brief_summary>
	<brief_title>Efficacy Study Tamsulosin Tolterodine Treatment Chronic Prostatitis</brief_title>
	<detailed_description>Chronic prostatitis/chronic pelvic pain syndrome ( CP/CPPS ) common disorder urological clinic . Most clinically CP/CPPS extent associate storage ( irritative ) symptom , increased frequency , urgency , nocturia , namely many patient CP/CPPS overactive bladder symptom . Alpha-blocker therapy advocate treatment modality CP/CPPS . Some trial show statistically likely clinically significant treatment effect , trial show benefit . Therefore , tamsulosin combination tolterodine treatment CP/CPPS may effective tamsulosin single .</detailed_description>
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<mesh_term>Prostatitis</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<criteria>1. diagnosis CP/CPPS base classification US National Institutes Health , age 1845 year 2. total score least 12 National Institutes Health Chronic Prostatitis Symptom Index ( NIHCPSI ) 3. urinary score least 4 CPSI 4. subject anticipate improve symptom 1. previous treatment alphaadrenergic receptor blocker antimuscarinic agent symptom CP/CPPS reason 2. previous urinary tract infection last year 3. treat take medication could affect low urinary tract function 4. meet criterion chronic bacterial prostatitis lower urinary tract localization study 5. significant medical problem</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>prostatitis</keyword>
	<keyword>Adrenergic alpha-Antagonists</keyword>
	<keyword>tolterodine</keyword>
</DOC>